How to accurately interpret liver biopsy (notice n° 173404)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02491cam a2200373 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112035650.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Fontanges, Thierry |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | How to accurately interpret liver biopsy |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2022.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 69 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Liver biopsy practice has decreased in recent years due to the use of noninvasive tests that are easier and more comfortable for the patient. However, this procedure remains mandatory in certain conditions: when major gaps are detected between several noninvasive tests; for ascertaining the etiology of liver damage when blood and morphological tests are not successful; and finally for therapeutic protocols. The main objective of this article is to help the practitioner understand and interpret the results of a biopsy in order to extract as much information as possible: sample quality, collaboration between the practitioner and the pathologist, location and type of lesion, and finally classification of liver fibrosis based on approved data. Precious information gathered from the patient on their medical background will also greatly help the pathologist in their interpretation. Throughout a chronic liver disease, it is of utmost importance to rely on a solid clinical history for the patient’s follow-up care. If acute alcoholic hepatitis is suspected, this biopsy remains unavoidable to confirm the diagnosis and decide on the therapeutic strategy. In other words, liver biopsy is synonymous with rigorousness and remains important for the practitioner. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | characterization of histological lesions |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | practitioner-pathologist collaboration |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vascular damage |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | quality criteria |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | drug-induced lesions |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | liver biopsy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cytolytic and/or cholestatic hepatitis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | steatopathy and associated lesions |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | classification of fibrosis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Hepatic biopsy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Classification of fibrosis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Practitioner-pathologist collaboration |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Steatopathy and associated lesions |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Quality criteria |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | drug-induced lesions |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Characterization of histological lesions |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cytolytic and/or cholestatic hepatitis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Vascular damage |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hegel | - | 4 | 2022-11-22 | p. 316-326 | 2269-0530 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-hegel-2022-4-page-316?lang=en">https://shs.cairn.info/journal-hegel-2022-4-page-316?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux